GENESIS Pharma is one of the most successful Greek trading companies, showing significant growth. It ranks among the largest pharmaceutical companies operating in the Greek market and is consistently in the top positions in hospital sales in the country.
In 2011 the company's turnover reached € 212 million on a consolidated basis.
The economic contribution of GENESIS Pharma in the Greek economy from taxes and funds, exceeded € 65 million during 2009-2011, while at the same period the company paid for wages, salaries and staff benefits the amount of € 36 million.
Consolidated Turnover* The reduction is purely a result of the 25% and 27% price reductions imposed on pharmaceuticals within the new pricing policy for the Greek pharmaceutical market in 2010. 222,9*255,2223,4172,4154,4132,5’10’09’08’07’06In million €’05250200150100500